US FDA Delays Decisions Due to Sandy; J&J Drug Wins Wider Approval

Published November 4, 2012

US FDA Delays Decisions Due to Sandy; J&J Drug Wins Wider Approval

Filed under: drug treatment news 2012

Xarelto is the first oral anti-clotting drug approved to treat and reduce the recurrence of blood clots since the approval of warfarin 60 years ago," the FDA said in a release.Also Friday:Amgen (NASDAQ: AMGN)will … Antares Pharma, Inc. (NASDAQ: ATRS …
Read more on Equities.com

Medivation, Astellas Prostate Cancer Drug Soars in First Weeks on Market

Filed under: drug treatment news 2012

By Brett Chase Nov 01, 2012 11:50 am. The drug Xtandi is forecast to generate $ 100 million in sales in first six months. PRINT · 1 Comment. All the News and Insights You Need Right in Your Inbox | Sign Up for Our Free Newsletter. MINYANVILLE ORIGINAL …
Read more on Minyanville.com

Researchers seek to improve drug delivery with hydrogels

Filed under: drug treatment news 2012

Researchers in Japan have developed a technique which allows them to control and target drug delivery to specific sites of the body at specific times, thus reducing side effects and improving treatment dramatically. The results were published recently …
Read more on Phys.Org